Current Approaches to Management of Bone Sarcomas in Adolescent and Young Adult (AYA) Patients
Bone sarcomas are routinely diagnosed in the adolescent and young adult population.
Category
  • Sarcoma
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Radiotherapy for Leukemia: Past, Present and Future
The use of radiotherapy (RT) in the management of leukemia has evolved. Historically, RT was critical for disease control in sanctuary sites, such as the central nervous system (CNS) and testes.
Category
  • Pediatric
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Advances in Sarcoma Treatment
Sarcomas are a rare and heterogenous group of malignancies requiring a multidisciplinary approach for optimal management.
Category
  • Sarcoma
Format
  • onDemand
  • Webinars
Credits
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 Certificate of Attendance
Cost $299.00
2024 ASTRO Annual Refresher Course onDemand
This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most major sub-disciplines of radiation oncology, including sarcomas, pediatrics and lymphomas, and the role of radiotherapy in the multidiscipl
Category
  • Breast
  • Central Nervous System
  • Gastrointestinal
  • Genitourinary
  • Gynecologic
  • Head and Neck
  • Hematologic
  • Pediatric
  • Physics
  • Radiobiology
  • Sarcoma
  • Thoracic
Format
  • Meetings onDemand
Credits
  • 22.75 AMA PRA Category 1 Credit™
  • 22.75 Certificate of Attendance
Cost $1,049.00
2025 ASTRO Annual Refresher Course onDemand
This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most major subdisciplines of radiation oncology, including sarcomas, pediatrics and lymphomas, and the role of radiotherapy in the multidiscipli
Category
Format
  • Meetings onDemand
Credits
  • 24.25 AMA PRA Category 1 Credit™
  • 24.25 Certificate of Attendance
Cost $1,049.00
Gray Zone - Which Way to (INDI)GO?
The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.
Category
  • Central Nervous System
  • Gastrointestinal
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $0.00
Gray Zone - Conebeam CT Scan Reveals a Space Invader: Fire All Beams or Fall Back?
The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.
Category
  • Head and Neck
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $0.00
2026 Multidisciplinary Radiopharmaceutical Therapy Symposium onDemand
The 2026 Multidisciplinary Radiopharmaceutical Therapy Symposium is a two-day meeting featuring interactive and case-based educational sessions that focus on the evolving utilization of and advancements in radiopharmaceuticals in the treatment of cancer and other indications.
Category
  • Radiopharmaceutical Therapy
Format
  • Meetings onDemand
Credits
  • 13.25 AMA PRA Category 1 Credit™
  • 13.25 Certificate of Attendance
Cost $1,799.00
A Case-based Guide for World Health Organization (WHO) Grade 2 Meningioma Radiosurgery and Radiotherapy from The Radiosurgery Society
This journal activity presents consensus effort guidelines for managing meningioma with radiotherapy.Please visit this LINK to read the related journal article online. 
Category
  • Central Nervous System
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
A Randomized Study of Consolidation Chemoradiation (CTRT) versus Observation after first line chemotherapy (CT) in Advanced Gall Bladder Cancers (GBC): Race-GB Study
Management of unresectable gall bladder cancer (GBC) is challenging, and it can be especially so in Low-to-Middle Income Countries (LMIC), as <50% of patients complete the standard 6 cycles of CT.  This article presents the results of a single center, open label, randomized trial evaluating co
Category
  • Gastrointestinal
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $49.00

Pages